26th August, 2024
Combining advanced imaging with precise treatment delivery
image credit- shutterstock
Varian, a Siemens Healthineers company, announced the launch of HyperSight imaging solution for its TrueBeam and Edge systems across the Asia Pacific region (excluding China). This upgrade gives clinicians advanced image quality, enhancing their ability to deliver precise and efficient radiation therapy treatments.
HyperSight optimizes workflows across Varian’s entire suite of linear accelerators, enabling more tailored treatment for each patient. HyperSight acquires high-quality images and offers an extended field of view during a patient's daily radiation treatments, which is particularly beneficial for treating large cancers, facilitating accurate tumor volume targeting, reduced target volume margins, and preserved healthy tissue. It provides Hounsfield Unit (HU) accuracy needed for treatment planning directly on the acquired conebeam CT (CBCT) images, allowing clinicians to calculate changes in tumors and surrounding organs with greater precision, helping to adjust treatments more effectively, thereby eliminating the need for separate CT scans, potentially avoiding extensions to a patient’s hospital stay. HyperSight is designed for all anatomical sites and has a 50 percent faster gantry rotation compared to traditional CBCT scans, which can take up to 60 seconds. For existing TrueBeam and Edge users, the upgrade seamlessly integrates with their systems, reducing motion-related artifacts due to patient movement and minimizing discomfort from prolonged treatment times.
The Asia Pacific region is facing a growing radiotherapy demand, with clinicians burdened by increased patient volumes and limited access to advanced technologies. Varian is supporting healthcare providers with an innovative portfolio of radiotherapy solutions, including HyperSight, and is working with regulators to review reimbursement models to support optimal patient care.
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer